Jarl Ulf Birger Jungnelius

Jarl Ulf Birger Jungnelius

Director/Board Member bij ONCOPEPTIDES AB

Vermogen: 35 106 $ op 31-03-2024

73 jaar
Health Technology
Consumer Services
Distribution Services

Profiel

Jarl Ulf Birger Jungnelius is currently an Independent Director at Oncopeptides AB, a Director at CarpoNovum AB, a Director at Beactica Therapeutics AB, an Independent Director at Biovica International AB, a Director at Mesothelioma Applied Research Foundation, Inc., a Director at Monocl AB, the Chief Medical Officer at NOXXON Pharma AG, and the Managing Partner at Healthcom GmbH.
He previously served as the Chairman at Isofol Medical AB, the VP-Clinical Research & Development, Solid Tumors at Celgene Corp., the Principal at Eli Lilly & Co., the Vice President-Oncology Clinical Development at Takeda Corp., and the Full Development Leader at Pfizer NV.
He was also a Member-Supervisory Board at Ryvu Therapeutics SA and an Advisor-Senior Medical at TME Pharma NV.
He holds a doctorate degree from Karolinska Institutet.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
31-12-2022 57 750 ( 0.06% ) 35 106 $ 31-03-2024

Actieve functies van Jarl Ulf Birger Jungnelius

BedrijvenFunctieBegin
ONCOPEPTIDES AB Director/Board Member 01-04-2011
BIOVICA INTERNATIONAL AB Director/Board Member 01-01-2014
Mesothelioma Applied Research Foundation, Inc. Director/Board Member -
Director/Board Member 01-03-2013
Chief Tech/Sci/R&D Officer 01-02-2017
Healthcom GmbH Corporate Officer/Principal 01-05-2014
Director/Board Member 19-06-2023
Director/Board Member -
Alle actieve functies van Jarl Ulf Birger Jungnelius

Eerdere bekende functies van Jarl Ulf Birger Jungnelius

BedrijvenFunctieEinde
ISOFOL MEDICAL AB Chief Executive Officer 28-02-2023
░░░ ░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░ ░░░░░ ░░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
Ervaring van Jarl Ulf Birger Jungnelius in detail bekijken

Opleiding van Jarl Ulf Birger Jungnelius

Karolinska Institutet Doctorate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Jarl Ulf Birger Jungnelius in detail bekijken

Connecties

100 +

Eerstegraads connecties

16

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven6
ELI LILLY AND COMPANY

Health Technology

ONCOPEPTIDES AB

Health Technology

BIOVICA INTERNATIONAL AB

Health Technology

ISOFOL MEDICAL AB

Health Technology

RYVU THERAPEUTICS S.A.

Health Technology

TME PHARMA N.V.

Health Technology

Bedrijven in privébezit9

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

Pfizer NV/SA

Mesothelioma Applied Research Foundation, Inc.

Technology Services

Healthcom GmbH

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Jarl Ulf Birger Jungnelius